Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Japanese Journal of Clinical Oncology|January 10, 2018
A Phase I/II study of the combination of lapatinib and oral vinorelbine in HER2-positive metastatic breast cancerTom Wei-Wu Chen, Dah-Cherng Yeh, Tsu-Yi Chao, et al.
Investigational New Drugs|March 3, 2019
A phase I study of pexidartinib, a colony-stimulating factor 1 receptor inhibitor, in Asian patients with advanced solid tumorsJih-Hsiang Lee, Tom Wei-Wu Chen, Chih-Hung Hsu, et al.
JCO Precision Oncology|June 29, 2026
Integrating DNA Mutations and RNA Expression of Cancer Driver Genes in Asian Rare Cancers: A Pan-Cancer AnalysisKathleen Yasmin de Almeida, Marcelo Severino B Imasa, Pei Jye Voon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2022
A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and LeiomyosarcomaTom Wei-Wu Chen, Chia-Lang Hsu, Ruey-Long Hong, et al.
Breast Cancer Research and Treatment|June 21, 2023
Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancerTom Wei-Wu Chen, Wen Hsiao, Ming-Shen Dai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2015
Bevacizumab preconditioning followed by Etoposide and Cisplatin is highly effective in treating brain metastases of breast cancer progressing from whole-brain radiotherapyYen-Shen Lu, Tom Wei-Wu Chen, Ching-Hung Lin, et al.
Scientific Reports|December 17, 2015
TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 AssaysChing-Hung Lin, I-Chiun Chen, Chiun-Sheng Huang, et al.
Nature Communications|March 26, 2026
Tazemetostat, an EZH2 inhibitor, in solid tumors harboring SWI/SNF alterations: a phase II basket studyMrinal Gounder, Patrick Schöffski, Robin L Jones, et al.
Neurospine|January 3, 2024
Delay of Surgery for Spinal Metastasis due to the COVID-19 Outbreak Affected Patient OutcomesChia-Jung Hsieh, Chun-Yu Wu, Yen-Heng Lin, et al.
Cancer|July 7, 2022
Soft tissue sarcoma incidences and clinical characteristics are significantly different in France and TaiwanTom Wei-Wu Chen, Ruru Chun-Ju Chiang, Alex Le Cesne, et al.
Pageof 8